us > Maine > Oxford > Gilead > Latest & Local News
→ Put text on photo fast and free
Gilead news
Gilead Sciences appoints Houbara Communications as PR partner - Campaign Middle East
Gilead Sciences appoints Houbara Communications as PR partner Campaign Middle East
Published on 6 June 2024 | 8:55 am
Gilead's seladelpar shows promise in primary biliary cholangitis trial - Clinical Trials Arena
Gilead's seladelpar shows promise in primary biliary cholangitis trial Clinical Trials Arena
Published on 6 June 2024 | 8:45 am
Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN ... - businesswire.com
Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN ... businesswire.com
Published on 6 June 2024 | 8:30 am
Gilead reached agreement in principle to resolve federal TDF litigation - TipRanks.com - TipRanks
Gilead reached agreement in principle to resolve federal TDF litigation - TipRanks.com TipRanks
Published on 5 June 2024 | 3:54 pm
Gilead, Ipsen Tout Phase III Primary Biliary Cholangitis Data as PDUFA Dates Loom - BioSpace
Gilead, Ipsen Tout Phase III Primary Biliary Cholangitis Data as PDUFA Dates Loom BioSpace
Published on 5 June 2024 | 3:21 pm
Vir Seeks to Challenge Gilead With Phase II Hepatitis Delta Data - BioSpace
Vir Seeks to Challenge Gilead With Phase II Hepatitis Delta Data BioSpace
Published on 5 June 2024 | 2:54 pm
Pharmalittle: We're reading about MDMA 'no' votes, a Gilead settlement, and more - STAT
Pharmalittle: We're reading about MDMA 'no' votes, a Gilead settlement, and more STAT
Published on 5 June 2024 | 1:24 pm
Readout Newsletter: Gilead, Biomarin, Lykos, AstraZeneca news - STAT
Readout Newsletter: Gilead, Biomarin, Lykos, AstraZeneca news STAT
Published on 5 June 2024 | 1:19 pm
Gilead Sciences: Preserving Fertility in the Face of a Cancer Diagnosis - Yahoo Finance
Gilead Sciences: Preserving Fertility in the Face of a Cancer Diagnosis Yahoo Finance
Published on 5 June 2024 | 1:15 pm
Settlement reached in suit claiming Gilead delayed HIV treatment - STAT
Settlement reached in suit claiming Gilead delayed HIV treatment STAT
Published on 5 June 2024 | 1:09 pm
Gilead strengthens seladelpar case in PBC - The Pharma Letter
Gilead strengthens seladelpar case in PBC The Pharma Letter
Published on 5 June 2024 | 12:33 pm
Gilead, Ipsen build the case for their PBC drugs at EASL - pharmaphorum
Gilead, Ipsen build the case for their PBC drugs at EASL pharmaphorum
Published on 5 June 2024 | 11:34 am
Gilead shows $4.3B liver drug improves outcomes out to 2 years - Fierce Biotech
Gilead shows $4.3B liver drug improves outcomes out to 2 years Fierce Biotech
Published on 5 June 2024 | 11:33 am
Gilead progresses subject enrolment in HIV prevention trials - Clinical Trials Arena
Gilead progresses subject enrolment in HIV prevention trials Clinical Trials Arena
Published on 5 June 2024 | 9:41 am
Gilead Sciences' (GILD) Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile ... - StreetInsider.com
Gilead Sciences' (GILD) Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile ... StreetInsider.com
Published on 5 June 2024 | 9:23 am
Mount Gilead BOE hears optimistic financial forecast - Morrow County Sentinel
Mount Gilead BOE hears optimistic financial forecast Morrow County Sentinel
Published on 5 June 2024 | 8:15 am
Gilead price tries to recoup some losses - Forecast today - 05-06-2024 - Economies.com
Gilead price tries to recoup some losses - Forecast today - 05-06-2024 Economies.com
Published on 5 June 2024 | 7:02 am
Gilead's Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary ... - businesswire.com
Gilead's Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary ... businesswire.com
Published on 5 June 2024 | 6:00 am
National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention Injection - AOL
Published on 4 June 2024 | 9:59 pm
National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention Injectio - Benzinga
Published on 4 June 2024 | 7:57 pm
HIV drugmaker agrees to $40M settlement over delayed treatment rollout - San Francisco Chronicle
HIV drugmaker agrees to $40M settlement over delayed treatment rollout San Francisco Chronicle
Published on 4 June 2024 | 7:56 pm
Gilead's Kite announces updated OS data from ZUMA-3 study of Tecartus - TipRanks.com - TipRanks
Gilead's Kite announces updated OS data from ZUMA-3 study of Tecartus - TipRanks.com TipRanks
Published on 4 June 2024 | 2:10 pm
The Zacks Analyst Blog Highlights NextEra Energy, BP, Gilead Sciences, Hamilton Beach and FONAR - Yahoo Finance
The Zacks Analyst Blog Highlights NextEra Energy, BP, Gilead Sciences, Hamilton Beach and FONAR Yahoo Finance
Published on 4 June 2024 | 1:11 pm
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study - Yahoo Finance
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study Yahoo Finance
Published on 3 June 2024 | 5:59 pm
Top Stock Reports for NextEra Energy, BP & Gilead Sciences - Yahoo Finance
Top Stock Reports for NextEra Energy, BP & Gilead Sciences Yahoo Finance
Published on 3 June 2024 | 5:07 pm
ASCO 2024: Gilead and Arcus present anti-TIGIT domvanalimab plus zimberelimab data - The Pharma Letter
ASCO 2024: Gilead and Arcus present anti-TIGIT domvanalimab plus zimberelimab data The Pharma Letter
Published on 3 June 2024 | 9:45 am
'We're going to miss the next Keytruda': Lilly, Merck, Gilead and PhRMA CEOs talk IRA consequences - FiercePharma
'We're going to miss the next Keytruda': Lilly, Merck, Gilead and PhRMA CEOs talk IRA consequences FiercePharma
Published on 2 June 2024 | 8:33 pm
ASCO: Gilead sifts lung cancer data for efficacy crumbs - pharmaphorum
ASCO: Gilead sifts lung cancer data for efficacy crumbs pharmaphorum
Published on 2 June 2024 | 9:14 am
Gilead to present EVOKE-01 study data at ASCO meeting - TipRanks.com - TipRanks
Gilead to present EVOKE-01 study data at ASCO meeting - TipRanks.com TipRanks
Published on 1 June 2024 | 4:04 pm
Gilead - National Endowment for the Arts
Gilead National Endowment for the Arts
Published on 1 June 2024 | 3:46 pm
Gilead drug fails to confirm its FDA approval in bladder cancer - The Business Journals
Gilead drug fails to confirm its FDA approval in bladder cancer The Business Journals
Published on 31 May 2024 | 9:55 pm
Gilead Sciences ADC Flunks Its Confirmatory Test in Advanced Bladder Cancer - MedCity News
Gilead Sciences ADC Flunks Its Confirmatory Test in Advanced Bladder Cancer MedCity News
Published on 31 May 2024 | 5:03 pm
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal - Yahoo Finance
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal Yahoo Finance
Published on 31 May 2024 | 5:01 pm
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival - Reuters
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival Reuters
Published on 31 May 2024 | 4:13 pm
Gilead’s Trodelvy Fails to Reach Primary Endpoint in Confirmatory Trial - BioSpace
Gilead’s Trodelvy Fails to Reach Primary Endpoint in Confirmatory Trial BioSpace
Published on 31 May 2024 | 3:06 pm
Gilead's Trodelvy Fails To Show Significant Survival Benefit - Finimize
Gilead's Trodelvy Fails To Show Significant Survival Benefit Finimize
Published on 31 May 2024 | 2:04 pm
ASCO: Gilead looks for silver lining in Trodelvy's failed lung cancer trial. But will the FDA play ball? - FiercePharma
ASCO: Gilead looks for silver lining in Trodelvy's failed lung cancer trial. But will the FDA play ball? FiercePharma
Published on 31 May 2024 | 12:00 pm
Phase III trial miss shakes faith in Gilead's Trodelvy - The Pharma Letter
Phase III trial miss shakes faith in Gilead's Trodelvy The Pharma Letter
Published on 31 May 2024 | 11:32 am
Gilead's urothelial cancer trial fails to meet primary endpoint - Clinical Trials Arena
Gilead's urothelial cancer trial fails to meet primary endpoint Clinical Trials Arena
Published on 31 May 2024 | 8:26 am
Gilead's Trodelvy woes rise with failed bladder cancer trial - pharmaphorum
Gilead's Trodelvy woes rise with failed bladder cancer trial pharmaphorum
Published on 31 May 2024 | 7:39 am
Gilead's Trodelvy suffers double whammy as failed bladder cancer trial raises flag over early deaths - FiercePharma
Gilead's Trodelvy suffers double whammy as failed bladder cancer trial raises flag over early deaths FiercePharma
Published on 30 May 2024 | 10:20 pm
Gilead Provides Update on Phase 3 TROPiCS-04 Study - businesswire.com
Gilead Provides Update on Phase 3 TROPiCS-04 Study businesswire.com
Published on 30 May 2024 | 8:45 pm
Gilead urged to improve access to HIV drug by public figures and celebrities - Pharmaceutical Technology
Gilead urged to improve access to HIV drug by public figures and celebrities Pharmaceutical Technology
Published on 30 May 2024 | 7:20 pm
Cytiva rolls out new CAR-T manufacturing platform developed with Gilead's Kite - FiercePharma
Cytiva rolls out new CAR-T manufacturing platform developed with Gilead's Kite FiercePharma
Published on 30 May 2024 | 1:19 pm
Celebrities join campaigners in call for cheaper version of ‘gamechanger’ HIV drug for poorer countries - The Guardian
Celebrities join campaigners in call for cheaper version of ‘gamechanger’ HIV drug for poorer countries The Guardian
Published on 30 May 2024 | 7:13 am
Truvada Lawsuit - Lawsuit Information Center Blog
Truvada Lawsuit Lawsuit Information Center Blog
Published on 29 May 2024 | 1:53 pm
Gilead and Cartography enter deal to develop cancer therapies - Pharmaceutical Technology
Gilead and Cartography enter deal to develop cancer therapies Pharmaceutical Technology
Published on 29 May 2024 | 9:54 am
Gilead draws up $20M pact with cancer biotech Cartography - Fierce Biotech
Gilead draws up $20M pact with cancer biotech Cartography Fierce Biotech
Published on 28 May 2024 | 7:00 am
The Handmaid's Tale Season 6's Actor Change Is A Big Step Forward For Gilead's Replacement - Screen Rant
The Handmaid's Tale Season 6's Actor Change Is A Big Step Forward For Gilead's Replacement Screen Rant
Published on 28 May 2024 | 2:20 am
Gilead FOCUS Program: Transforming Health Systems to Create Health Equity - Gilead Sciences
Gilead FOCUS Program: Transforming Health Systems to Create Health Equity Gilead Sciences
Published on 23 May 2024 | 9:46 pm
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of ... - Yahoo Finance
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of ... Yahoo Finance
Published on 22 May 2024 | 7:00 am
Gilead Sciences revenue 2006-2023 - Statista
Gilead Sciences revenue 2006-2023 Statista
Published on 22 May 2024 | 7:00 am
Gilead liver disease med still delivers ahead of FDA verdict - Fierce Biotech
Gilead liver disease med still delivers ahead of FDA verdict Fierce Biotech
Published on 20 May 2024 | 7:00 am
Gilead HIV Drugs Don't Infringe Axed US Patents, Judge Clarifies - Bloomberg Law
Gilead HIV Drugs Don't Infringe Axed US Patents, Judge Clarifies Bloomberg Law
Published on 10 May 2024 | 7:00 am
Will Gilead Sciences Stock Recover To Its Pre-Inflation Shock Highs Of Around $75? - Forbes
Will Gilead Sciences Stock Recover To Its Pre-Inflation Shock Highs Of Around $75? Forbes
Published on 9 May 2024 | 7:00 am
AHF • AHF's 'Gilead for Greed' Lampoons Gilead Hypocrisy '...for Good' - aidshealth.org
AHF • AHF's 'Gilead for Greed' Lampoons Gilead Hypocrisy '...for Good' aidshealth.org
Published on 7 May 2024 | 7:00 am
Forbes Has Listed Gilead as One of America's Best Employers for Diversity - Yahoo Finance
Forbes Has Listed Gilead as One of America's Best Employers for Diversity Yahoo Finance
Published on 3 May 2024 | 7:00 am
Gilead HIV drug case to be heard by California court - STAT - STAT
Gilead HIV drug case to be heard by California court - STAT STAT
Published on 2 May 2024 | 7:00 am
Gilead HIV Drug Case Gets California Supreme Court Look (1) - Bloomberg Law
Gilead HIV Drug Case Gets California Supreme Court Look (1) Bloomberg Law
Published on 2 May 2024 | 7:00 am
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data - Clinical Trials Arena
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data Clinical Trials Arena
Published on 29 April 2024 | 7:00 am
Gilead gives up on $4.9B antibody magrolimab - Fierce Biotech
Gilead gives up on $4.9B antibody magrolimab Fierce Biotech
Published on 26 April 2024 | 7:00 am
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline - BioSpace
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline BioSpace
Published on 26 April 2024 | 7:00 am
Gilead writes $2.4B off Trodelvy as CEO underscores 'time of focused execution' - FiercePharma
Gilead writes $2.4B off Trodelvy as CEO underscores 'time of focused execution' FiercePharma
Published on 26 April 2024 | 7:00 am
Gilead posts quarterly loss on acquisition charge, revenue rises 5% - Reuters
Gilead posts quarterly loss on acquisition charge, revenue rises 5% Reuters
Published on 25 April 2024 | 7:00 am
Gilead’s quarterly loss is narrower than expected - MarketWatch
Gilead’s quarterly loss is narrower than expected MarketWatch
Published on 25 April 2024 | 7:00 am
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ... - PR Newswire
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ... PR Newswire
Published on 18 April 2024 | 7:00 am
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for Yahoo Finance
Published on 18 April 2024 | 7:00 am
Gilead finds new way to raise HIV awareness, locking in with dancer for voguing workshop - FiercePharma
Gilead finds new way to raise HIV awareness, locking in with dancer for voguing workshop FiercePharma
Published on 3 April 2024 | 7:00 am
Ropes & Gray Advises Xilio Therapeutics in Gilead Sciences Exclusive Global License Agreement Up to $647.5 Million ... - Ropes & Gray LLP
Ropes & Gray Advises Xilio Therapeutics in Gilead Sciences Exclusive Global License Agreement Up to $647.5 Million ... Ropes & Gray LLP
Published on 27 March 2024 | 7:00 am
Gilead Sciences Announces Completion of Acquisition of CymaBay - Yahoo Finance
Gilead Sciences Announces Completion of Acquisition of CymaBay Yahoo Finance
Published on 22 March 2024 | 7:00 am
Gilead CEO Daniel O'Day collects 5% pay raise to $22.6M, his largest compensation package in years - FiercePharma
Gilead CEO Daniel O'Day collects 5% pay raise to $22.6M, his largest compensation package in years FiercePharma
Published on 19 March 2024 | 7:00 am
Gilead CAR-T cancer therapy capacity to quadruple by 2026 - Reuters
Gilead CAR-T cancer therapy capacity to quadruple by 2026 Reuters
Published on 15 March 2024 | 7:00 am
Study: Gilead antiviral drug shows promise as a treatment for Ebola Sudan - STAT
Study: Gilead antiviral drug shows promise as a treatment for Ebola Sudan STAT
Published on 14 March 2024 | 7:00 am
AIDS advocates welcome 'greedy Gilead' to Miami with protests - FiercePharma
AIDS advocates welcome 'greedy Gilead' to Miami with protests FiercePharma
Published on 14 March 2024 | 7:00 am
Gilead launches patient hub to 'expose' realities of living with metastatic breast cancer - FiercePharma
Gilead launches patient hub to 'expose' realities of living with metastatic breast cancer FiercePharma
Published on 11 March 2024 | 7:00 am
Gilead, Merus Ink Potential $1.5B Deal for T-Cell Engagers - BioSpace
Gilead, Merus Ink Potential $1.5B Deal for T-Cell Engagers BioSpace
Published on 7 March 2024 | 8:00 am
Key takeaways from Gilead's Innovation Talk at re:Invent 2023 | Amazon Web Services - AWS Blog
Key takeaways from Gilead's Innovation Talk at re:Invent 2023 | Amazon Web Services AWS Blog
Published on 6 March 2024 | 8:00 am
Gilead Sciences Signs Yet Another R&D Alliance for Multi-Target Cancer Therapies - MedCity News
Gilead Sciences Signs Yet Another R&D Alliance for Multi-Target Cancer Therapies MedCity News
Published on 6 March 2024 | 8:00 am
CymaBay Investor Alleges Gilead Buyout Filing Omits Conflicts - Bloomberg Law
CymaBay Investor Alleges Gilead Buyout Filing Omits Conflicts Bloomberg Law
Published on 1 March 2024 | 8:00 am
In atypical Big Pharma-VC pact, Gilead secures $210M from Abingworth to fund Trodelvy trials - FiercePharma
In atypical Big Pharma-VC pact, Gilead secures $210M from Abingworth to fund Trodelvy trials FiercePharma
Published on 29 February 2024 | 8:00 am
Gilead funding aimed at Black women and girls impacted by HIV - FiercePharma
Gilead funding aimed at Black women and girls impacted by HIV FiercePharma
Published on 28 February 2024 | 8:00 am
PhRMA taps Gilead CEO Dan O'Day as its new board chair - FiercePharma
PhRMA taps Gilead CEO Dan O'Day as its new board chair FiercePharma
Published on 21 February 2024 | 8:00 am
Yet another clinical hold for Gilead’s magrolimab trials - Pharmaceutical Technology
Yet another clinical hold for Gilead’s magrolimab trials Pharmaceutical Technology
Published on 19 February 2024 | 8:00 am
Gilead aims to cash in on liver disease wave with $4.6bn CymaBay deal - Pharmaceutical Technology
Gilead aims to cash in on liver disease wave with $4.6bn CymaBay deal Pharmaceutical Technology
Published on 13 February 2024 | 8:00 am
Gilead to buy CymaBay for $4.3 bln in bets on liver disease treatment - Reuters
Gilead to buy CymaBay for $4.3 bln in bets on liver disease treatment Reuters
Published on 12 February 2024 | 8:00 am
AHF • AHF Hammers Gilead Over Continued Profiteering - aidshealth.org
AHF • AHF Hammers Gilead Over Continued Profiteering aidshealth.org
Published on 8 February 2024 | 8:00 am
US FDA puts hold on Gilead's blood cancer therapy trials - Reuters
US FDA puts hold on Gilead's blood cancer therapy trials Reuters
Published on 7 February 2024 | 8:00 am
Gilead's at 'just the beginning' of cell therapy movement: exec - FiercePharma
Gilead's at 'just the beginning' of cell therapy movement: exec FiercePharma
Published on 7 February 2024 | 8:00 am
Gilead Sciences raises stake in cancer-centric Arcus Biosciences to 33% - Reuters
Gilead Sciences raises stake in cancer-centric Arcus Biosciences to 33% Reuters
Published on 29 January 2024 | 8:00 am
What to make of Gilead's Trodelvy troubles and Elevation Oncology's rise - STAT
What to make of Gilead's Trodelvy troubles and Elevation Oncology's rise STAT
Published on 25 January 2024 | 8:00 am
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff - FiercePharma
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff FiercePharma
Published on 22 January 2024 | 8:00 am
Gilead $247 Million Antitrust Deal Over HIV Drugs Gets Final Nod - Bloomberg Law
Gilead $247 Million Antitrust Deal Over HIV Drugs Gets Final Nod Bloomberg Law
Published on 20 January 2024 | 8:00 am
Gilead cuts 7% of staff at Kite Pharma unit as 'refreshed business strategy' introduced - FiercePharma
Gilead cuts 7% of staff at Kite Pharma unit as 'refreshed business strategy' introduced FiercePharma
Published on 29 November 2023 | 8:00 am
Mt. Gilead Road Improvements Project - cityofkeller.com
Mt. Gilead Road Improvements Project cityofkeller.com
Published on 2 November 2023 | 10:16 pm
Advancing Health Equity | Gilead - Gilead Sciences
Advancing Health Equity | Gilead Gilead Sciences
Published on 26 October 2023 | 7:00 am
Diversity in Clinical Trials - Gilead Sciences
Diversity in Clinical Trials Gilead Sciences
Published on 17 October 2023 | 12:49 pm
Zeroing In: Ending the HIV Epidemic | Gilead - Gilead Sciences
Zeroing In: Ending the HIV Epidemic | Gilead Gilead Sciences
Published on 21 August 2023 | 9:45 pm
Zeroing In: Ending the HIV Epidemic - Gilead Sciences
Zeroing In: Ending the HIV Epidemic Gilead Sciences
Published on 21 August 2023 | 9:45 pm